Jaundice Accompanied by Giant Cell Hepatitis and Eosinophilia in Childhood

REFERENCES

• 1 Bogdanos D P, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.  Liver. 2001;  21 225-232
• 2 Lerner M P, Donoso L A, Nordquist R E, Cunningham M W. Immunological mimicry between retinal S-antigen and group A streptococcal M proteins.  Autoimmunity. 1995;  22 95-106
• 3 Bonanni L, Parmiani S, Giammarini L et al.. Post-streptococcal nonallergic urticaria?.  Allergy. 2002;  57 558-560
• 4 Vento S, Garofano T, DiPerri G et al.. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.  Lancet. 1991;  337 1183-1187
• 5 Laskus T, Slusarczyk J. Autoimmune chronic active hepatitis developing after acute type B hepatitis.  Dig Dis Sci. 1989;  34 1294-1297
• 6 Vento S, Cainelli F, Renzini C, Concia E. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance.  Lancet. 1997;  350 1298-1299
• 7 Vento S, Guella L, Mirandola F et al.. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.  Lancet. 1995;  346 608-609
• 8 Kerkar N, Choudhuri K, Ma Y et al.. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.  J Immunol. 2003;  170 1481-1489
• 9 Tomer G, Shneider B L. Minocycline-induced hepatitis.  J Pediatr Gastroenterol Nutr. 2000;  30 105-106
• 10 Teitelbaum J E, Perez-Atayde A R, Cohen M, Bousvaros A, Jonas M M. Minocycline-related autoimmune hepatitis: case series and literature review.  Arch Pediatr Adolesc Med. 1998;  152 1132-1136
• 11 Phillips M J, Blandis L M, Poucell S et al.. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features.  N Engl J Med. 1991;  324 455-460
• 12 Brichard B, Sokal E, Gosseye S et al.. Coombs-positive giant cell hepatitis of infancy: effect of steroids and azathioprine therapy.  Eur J Pediatr. 1991;  150 314-317
• 13 Kumar A, Minuk G Y. Postinfantile giant cell hepatitis in association with hypereosinophilia.  Gastroenterology. 1991;  101 1417-1419
• 14 Fauci A S, Harley J B, Roberts W C et al.. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.  Ann Intern Med. 1982;  97 78-92
• 15 Foong A, Scholes J V, Gleich G J, Kephart G M, Holt P R. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.  Hepatology. 1991;  13 1090-1094
• 16 Croffy B, Kopelman R, Kaplan M. Hypereosinophilic syndrome. Association with chronic active hepatitis.  Dig Dis Sci. 1988;  33 233-239
• 17 Mulder A H, Horst G, Haagsma E B et al.. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.  Hepatology. 1993;  17 411-417
• 18 Duerr R H, Targan S R, Landers C J et al.. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.  Gastroenterology. 1991;  100 1385-1391
• 19 Klein R, Eisenburg J, Weber P, Seibold F, Berg P A. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis.  Hepatology. 1991;  14 1147-1152
• 20 Koskinas J, Deutsch M, Papaioannou C, Kafiri G, Hadziyannis S. Post-infantile giant cell hepatitis associated with autoimmune hepatitis and polyarteritis nodosa.  Scand J Gastroenterol. 2002;  37 120-123
• 21 Lohr H F, Schaak J F, Dienes H P et al.. Liver cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency type Pi MS and autoimmune features.  Digestion. 1995;  56 41-45
• 22 Alvarez F, Berg P A, Bianchi F B et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.  J Hepatol. 1999;  31 929-938